Interius BioTherapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Interius BioTherapeutics

Access the complete profile.

Interius BioTherapeutics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	3401 Grays Ferry Ave Building 200, Suite 300 Philadelphia, PA 19146

Note: Revenues for privately held companies are statistical evaluations.


Interius BioTherapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Interius BioTherapeutics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Interius BioTherapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Interius BioTherapeutics Annual Revenue and Growth Rate

Interius BioTherapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Interius BioTherapeutics's revenues are gauged from an analysis of company filings.

Interius BioTherapeutics's Income Statement (based on Industry Averages)

Interius BioTherapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Interius BioTherapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
June 3, 2024	12	62%	$83 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Interius BioTherapeutics is developing and marketing. Interius BioTherapeutics's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
INTERIUS pharmaceutical and biological preparations for use in the treatment of cancers, blood diseases, and blood disorders	09/15/2022

See all trademarks and details in the Full Report.

Market Share of Interius BioTherapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Interius BioTherapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Interius BioTherapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
WISTAR INSTITUTE OF ANATOMY & BIOLOGY	Philadelphia, PA	100
CENTURY THERAPEUTICS	Philadelphia, PA	94
AMICUS THERAPEUTICS US	Philadelphia, PA	83
AMERICAN ASSN FOR CANCER RES	Philadelphia, PA	72
CARISMA THERAPEUTICS	Philadelphia, PA	51
INTERIUS BIOTHERAPEUTICS	Philadelphia, PA	38

Future Competition: Interius BioTherapeutics's Fastest Growing Competitors

These companies are in the same general field as Interius BioTherapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)